Womens Health Devices Market size to exceed $42.5bn by 2025
Published Date: April 5, 2019 Authors: Sumant Ugalmugle
Women's Health Devices Market size is set to exceed USD 42.5 billion by 2025; according to a new research report by Global Market Insights.
Women’s health devices market is primarily driven by growing disease burden among women across the world. Growing number of gynecological cancers in developed as well as developing countries will surge the demand for advanced diagnostic and therapeutic devices thereby augmenting women health devices industry growth. Increasing disposable income coupled with advancements in healthcare infrastructure will drive the business revenue.
Furthermore, numerous government initiatives to increase awareness regarding women health will positively impact the industry growth. For instance, Janani Suraksha Yojana and Janani Shishu Suraksha Karyakram, initiated by the Government of India to support women health issues should upsurge the business revenue. Technological advancement in healthcare industry will boost the demand for early disease diagnosis and treatment that will spur the women health devices market size. However, lack of awareness regarding women health, especially in underdeveloped countries may negatively impact the industry growth.
Get more details on this report - Request Free Sample PDF
Devices segment was valued over USD 15 billion in 2018 and will witness significant growth in the foreseeable future. High incidence of chronic and infectious diseases among the female population will surge the demand for effective disease treatment, thereby fostering the segment growth. Technological advancement coupled with availability of minimally invasive technologies will further spur the segment size.
Diagnostic segment accounted for more than 25% revenue share in 2018 and will witness robust CAGR by 2025. Introduction of advanced diagnostics for early and better diagnosis of diseases will surge the segment growth. High demand for ultrasound, mammography and CT scans owing to growing disease burden will drive the diagnostic products business growth.
Female sterilization segment held considerable revenue in 2018 and is projected to show more than 6.7% CAGR during the analysis timeframe. Segment growth is attributable to growing inclination of females towards sterilization procedures to avoid the risk of unwanted pregnancy. According to the National Center for Health Statistics (NCHS) data, out of the total women opting for some type of contraception, more than 18.5% women chose female sterilization between 2015 and 2017. Increasing demand for permanent contraception will increase thus fuel the female sterilization segment growth.
Obstetrics & gynecology clinics segment accounted for over 17% revenue share in 2018 and is poised to show momentous growth during the forthcoming years. Increasing preference of women towards these clinics for various surgical as well as non-surgical gynecology procedures will upsurge the segmental revenue. Large number of women suffering from urinary incontinence, uterine fibroids or other gynecological diseases, opting for obstetrics & gynecology clinics will further fuel the business growth.
Browse key industry insights spread across 155 pages with 146 market data tables & 9 figures & charts from the report, “Women’s Health Devices Market Size By Type (Devices, Consumables), By Product (Surgical, Diagnostic, Contraceptives, Labor & Delivery, Critical Care), By Application (Cancer, Osteoporosis, Infectious Disease, Uterine Fibroids, Post-menopausal Syndrome, Pregnancy, Female Sterilization), By End-use (Hospitals, Obstetrics & Gynecology Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
North America women’s health devices market was valued more than USD 9 billion in 2018 and is estimated to grow exponentially over the forecast period. High prevalence of cancer in the region is the prime factor driving regional industry growth. According to the American Cancer Society, in 2019, approximately 891,480 new cancer cases are estimated among female population in the U.S. Increasing demand for technologically advanced diagnosis and treatment options will foster the North America women health devices industry growth.
Eminent industry players operating in women’s health devices market include Cardinal Health, Abbott Laboratories, Koninklijke Philips, CooperSurgical, F. Hoffmann-La Roche, Caldera Medical, GE Healthcare, Carestream Health, Hologic, Siemens, MedGyn Products, Prestige Consumer Healthcare and Medline Industries. Industry players adopt strategies such as geographic expansion, merger, acquisition as well as novel product launch to sustain market competition. For instance, in November 2016, Hologic launched next-generation NovaSure, an advanced global endometrial ablation system used in the treatment of abnormal uterine bleeding. This product launch enabled company to broaden its product portfolio and gain more market share.
Women’s health devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:
Women’s Health Devices Market, By Type (USD Million)
Women’s Health Devices Market, By Product (USD Million)
- Labor & delivery
- Critical care
Women’s Health Devices Market, By Application (USD Million)
- Infectious disease
- Uterine fibroids
- Post-menopausal syndrome
- Female sterilization
Women’s Health Devices Market, By End-use (USD Million)
- Obstetrics & gynecology clinics
- Diagnostic laboratories
- Ambulatory surgical centers
The above information is provided for the following regions and countries:
- North America
- Czech Republic
- Asia Pacific
- South Korea
- Latin America
- Middle East Asia & Africa
- Saudi Arabia
- South Africa